Search results
Results from the WOW.Com Content Network
Another study, this one from a French team, found that even among lupus patients with active SLE, the SARS-CoV-2 vaccines did not appear to cause a worsening of symptoms.
Turbo cancer is an anti-vaccination conspiracy theory [1] alleging that people vaccinated against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers.
The vaccine is given as an intradermal injection using a spring-powered jet injector. [2] [3] This is because successful transfection of DNA vaccines requires traveling across both the cell plasma membrane and the nuclear membrane, [4] and using a conventional needle gives poor results and leads to low immunogenicity. [4] [5]
It is a viral vector vaccine based on a human adenovirus that has been modified to contain the gene for making the spike protein of the SARS-CoV-2 virus that causes COVID‑19. [5] The body's immune system responds to this spike protein to produce antibodies. [29] The vaccine requires only one dose and does not need to be stored frozen. [30] [31]
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. [2] This candidate, named after a patriotic drama by Cuban independence hero José Martí, is a protein subunit vaccine containing COVID-derived proteins that trigger an immune response. [3]
Lupus is a chronic disease that can cause inflammation and pain in any part of the body. The disease impacts about 1.5 million Americans, but women are nine times more likely to develop lupus than ...
Significantly more people first developed tinnitus after the first dose of the vaccine, compared with the second. This suggests "that the vaccine is interacting with pre-existing risk factors for ...
Researchers at the Precision Vaccine Program at Boston Children's Hospital and Harvard Medical School, in Boston, Massachusetts, in collaboration with Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas, undertook a screening process that compared multiple molecules head-to-head in different ...